Search

Author/Creator McCulloch, William

2. Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma. Issue 10 (3rd October 2015)

Authors:
Kim, Ellen J.; Kim, Youn H.; Rook, Alain H.; Lerner, Adam; Duvic, Madeleine; Reddy, Sunil; Robak, Tadeusz; Becker, Jürgen C.; Samtsov, Alexey; McCulloch, William; Waksman, Joel; Whittaker, Sean
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 10(2015:Oct.)
Page Start:
2847
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors. (April 2021)

Authors:
Falchook, Gerald; Infante, Jeffrey; Arkenau, Hendrik-Tobias; Patel, Manish R.; Dean, Emma; Borazanci, Erkut; Brenner, Andrew; Cook, Natalie; Lopez, Juanita; Pant, Shubham; Frankel, Arthur; Schmid, Peter; Moore, Kathleen; McCulloch, William; Grimmer, Katharine; O'Farrell, Marie; Kemble, George; Bu...
Journal:
EClinicalMedicine
Issue:
Volume 34(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy. Issue 4 (3rd April 2018)

Authors:
Duvic, Madeleine; Bates, Susan E.; Piekarz, Richard; Eisch, Robin; Kim, Youn H.; Lerner, Adam; Robak, Tadeusz; Samtsov, Alexey; Becker, Jürgen C.; McCulloch, William; Waksman, Joel; Whittaker, Sean
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 4(2018)
Page Start:
880
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗